Becker's Healthcare September 16, 2024
Claire Wallace

New data from cancer screening and diagnostic test provider Exact Sciences have shown an 88.3% sensitivity rate for its blood-based colorectal cancer screening test.

The blood test also showed 31.2% sensitivity for advanced precancerous lesions at specificity of 90.1% for negative samples confirmed by colonoscopy, according to a Sept. 16 press release.

The study consisted of more than 3,000 blood samples, including approximately 2,900 blinded, using an analysis that was prespecified by the FDA.

The study also included more than 90 advanced...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Medical Devices, Provider
Phillips launches updated AI tech for MRI scanners
Medtronic partners with Brainomix on AI stroke tool
Biocompatible Nanoparticles: Tiny Antennae with Huge Potential for Brain-Computer Interfaces
Building Solid Relationships with Universities Critical for Early Stage Medtech Investors
Teleflex to split in 2, buy Biotronik assets for $791M among slew of actions

Share This Article